selected publications

• article

  • A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study.  Arthritis Research and Therapy.  18:-. 2016-01-01